Page last updated: 2024-10-26

valproic acid and Urinary Bladder, Neurogenic

valproic acid has been researched along with Urinary Bladder, Neurogenic in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Urinary Bladder, Neurogenic: Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.

Research Excerpts

ExcerptRelevanceReference
"Treatment with trichostatin A at 50 ng/mL decreased the collagen level in cells from neurogenic bladders to almost normal levels (2."1.36The effect of epigenetic therapy on congenital neurogenic bladders--a pilot study. ( Atala, A; Hodges, SJ; Mishra, N; Yoo, JJ, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hodges, SJ1
Yoo, JJ1
Mishra, N1
Atala, A1

Other Studies

1 other study available for valproic acid and Urinary Bladder, Neurogenic

ArticleYear
The effect of epigenetic therapy on congenital neurogenic bladders--a pilot study.
    Urology, 2010, Volume: 75, Issue:4

    Topics: Azacitidine; Cells, Cultured; Collagen; Epigenesis, Genetic; Genetic Therapy; Histone Deacetylase In

2010